IA
DERM icon

IFP Advisors’s Journey Medical DERM Stock Holding History

IFP Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,403
Closed -$12.5K – 3252
2024
Q1 		$12.5K Buy
+3,403
New +$14.8K ﹤0.01% 2158

Other funds holding DERM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

IFP Advisors's DERM Position: Q2 2024 in Review

IFP Advisors sold out of Journey Medical (DERM) in Q2 2024, closing a stake of 3,403 shares — an estimated $12.5K sold.

IFP Advisors first reported a position in DERM in Q1 2024 and held it in 1 quarter. The position peaked at $12.5K in Q1 2024. 35 funds tracked by Wall St. Rank hold DERM as of Q2 2024.

  • IFP Advisors reported no remaining Journey Medical position as of Q2 2024 after selling out during the quarter.
  • IFP Advisors sold 3,403 Journey Medical shares in Q2 2024, an estimated $12.5K.
  • IFP Advisors first reported a position in Journey Medical in Q1 2024 and held it in 1 quarter.
  • IFP Advisors's Journey Medical position peaked at $12.5K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Journey Medical as of Q2 2024.

Based on IFP Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.